Milestone Research on Meniere’s Disease by Visualizing Endolymphatic Hydrops Using Gadolinium-Enhanced Inner Ear MRI and the Challenges in Clinical Applications

Review Article

Austin J Radiol. 2015; 2(6): 1035.

Milestone Research on Meniere’s Disease by Visualizing Endolymphatic Hydrops Using Gadolinium-Enhanced Inner Ear MRI and the Challenges in Clinical Applications

Zou J1,2*, Pyykkö I¹, Yoshida T³, Gürkov R4, Shi H6, Li Y7, Zheng G², Zhao Z², Peng R², Zheng H², Yin S6,Hyttinen J8, Nakashima T³ and Naganawa S5

¹Hearing and Balance Research Unit, Field of Otolaryngology, School of Medicine, University of Tampere, Finland

²Department of Otolaryngology-Head and Neck Surgery, Changhai Hospital, Second Military Medical University, China

³Department of Otorhinolaryngology, Nagoya University, Graduate School of Medicine, Japan

4Department of Otorhinolaryngology-Head and Neck Surgery, University of Munich, Germany

5Department of Radiology, Nagoya University, Graduate School of Medicine, Japan

6Department of Otolaryngology-Head & Neck Surgery, Affiliated Sixth People’s Hospital of Shanghai Jiao Tong University, China

7Department of Radiology, Affiliated Sixth People’s Hospital of Shanghai Jiao Tong University, China

8Department of Electronics and Communications Engineering and BioMediTech, Tampere University of Technology, Finland

*Corresponding author: Zou J, Hearing and Balance Research Unit, Field of Oto-laryngology, School of Medicine, University of Tampere, Medisiinarinkatu 3, 33520 Tampere, Finland

Received: August 07, 2015; Accepted: September 01, 2015; Published: September 04, 2015

Abstract

This review discusses the history of detecting Endolymphatic Hydrops (EH) and collecting evidence to diagnose Meniere’s Disease (MD) using Gadoliniumenhanced Inner Ear MRI (Gd-IEMRI) and the challenges in clinical applications. EH was visualized in vivo using Gd-IEMRI in an animal model by Zou et al. in 2000 at the Karoliniska Institutet. The perilymphatic and endolymphatic spaces were observed separately in humans using Gd-IEMRI with a 1.5 T machine after transtympanic injection of Gadolinium Chelate (GdC) in 2005 at the University of Tampere. EH in patients with MD was clearly demonstrated by Nakashima et al. with a 3.0 T machine with a 3-Dimensional Fluid-Attenuated Inversion Recovery (3D-FLAIR) sequence in 2007 at Nagoya University. The oval window was shown to be the major pathway for GdC to enter the inner ear after transtympanic injection. Long-term hearing function assessment after intratympanic application of GdC showed no evidence of ototoxicity in patients. The image quality correlated with various coils in addition to the magnetic strength of MRI. Naganawa et al. developed the following sequences to improve sensitivity: 3-Dimensional Fluid-Attenuated Inversion Recovery (3D-FLAIR), Heavily T(2)-weighted (hT(2)W)-3D-FLAIR, subtracting a positive endolymph image from a positive perilymph image that was called HYDROPS (i.e., HYbriD of Reversed image Of Positive endolymph signal and native image of positive perilymph Signal), and the HYDROPS2-Mi2 method (i.e., HYbriD of Reversed image Of MR cisternography and a positive Perilymph Signal by heavily T2-weighted 3DFLAIR-Multiplied by T2). Computer-aided segmentation of endo- and perilymph spaces reduces the observer-dependence of hydrops quantification and allows for volumetric quantification.

Keywords: Meniere’s disease; MRI; Endolymphatichydrops; Diagnosis; Contrast agent

Introduction

Endolymphatic Hydrops (EH) is accepted as a typical pathological change in Meniere’s Disease (MD),which was independently described by KyoshiroYamakawa (1892-1980) [1] and by Charles Skinner Hallpike (1900-1979) and Hugh Cairns (1896-1952) in 1938 [2]. Traditionally, MD has been considered an idiopathic condition comprising episodic rotatory vertigo, fluctuant hearing loss and tinnitus. It was first described and defined per se by Prosper Menière (1799-1862) in his publication in September 1861 [3] and has had his name associated with it largely since that time. Since then, the additional symptoms of aural pressure, hyperacusis and ataxia have come to be associated with the condition. Currently, MD is diagnosed as possible MD, probable MD, definite MD, and certain MD according the guidelines provided by the American Academy of Otolaryngology-Head and Neck Foundation, Inc [4]. A diagnosis of certain MD was once only made after a postmortem histological study. However, this was changed by an MRI study with an animal model by Zou et al. that showed EH in vivo after intravenous injection of Gadolinium Chelate (GdC) [5,6]. A high dose of GdC was applied to induce enough distribution in the inner ear because the transport efficacy of GdC across the blood-perilymph barrier is poor, which had the risk of causing renal injury and even nephrogenic systemic fibrosis [7-9]. Thereafter, high contrast images of all cochlear turns were obtained after placing GdC on the round window membrane. Subsequently, the perilymphatic and endolymphatic spaces were first observed separately in humans in 2005 using a 1.5 T machine after transtympanic injection of GdC [10]. Clear visualization of EH in MD patients was first demonstrated in 2007 using a 3.0 T machine with a three-Dimensional Fluid-Attenuated Inversion Recovery (3D-FLAIR) sequence after transtympanic injection of GdC diluted eightfold with saline [11]. This review discusses the development of the technique and challenges during clinical applications.

Animal models of EH

It has been reported that EH might be induced in animals by surgically blocking the endolymphatic duct and sac, inducing immune injury of the endolymphatic sac (challenged with keyhole limpet hemocyanin, KLH), and using noise exposure [12-15]. The immune injury and noise exposure models were advantageous to explore the etiology of MD [16-20]. In the early phase following a secondary KLH challenge, hearing thresholds significantly increased simultaneously with the elevation of perilymph antibody levels. The degree of hydrops was not the only factor causing the hearing loss as well as elevated ration of the action potential to the summating potential. Scale-out hearing loss appeared in animals with severe degeneration of the striavascular is as well as the organ of Corti, which was associated with inflammatory cellular infiltration, especially in the perilymphatic space, even in the absence of KLH in the cochlea [14]. The surgical model focused on the target of the endolymphatic sac and was concerned with its function of absorbing endolymph. However, Kimura’s model was aggressive because it destroyed the endolymphatic duct and sac [12]. Zou et al. further improved the surgical model by gently dissecting the endolymphatic sac from the sigmoid sinus and covering its outer surface with tissue sealant (Figure 1). The endolymphatic sac was kept intact but was defunctionalized, and EH could be visualized during the acute stage (6 days after operation) with MRI [5,6,21]. Later on, immune injury of the inner ear was induced by challenging the round window with KLH, which mimicked MD secondary to the otitis media, and EH was visualized using MRI [22,23].